BioCopy is a multinational company headquartered in Switzerland with a large and modern R&D facility in Germany. Its large patent portfolio centers on high-throughput analyses with a large application spectrum, currently focused on the characterization of immune responses for drug discovery. The proprietary technology provides unique label-free measurements of molecular interactions, which can be applied in diagnostics, vaccine development, as well as lead and hit screening. BioCopy's award-winning team consist of experts in biology, physics, engineering, microsystems technology and business. Together, they are working towards paving the way for the medicine of tomorrow, in particular with regard to immunotherapeutics and novel vaccines. The R&D team is complemented by renowned board members, in particular, Rainer Boehm (ex-interim CEO and Chief Commercial and Medical Affairs Officer Novartis Pharma), Prof. Dr. Alexander von Gabain (co-founder of Intercell AG, now Valneva SE) and Pascal Brenneisen (ex-CEO Novartis Switzerland).